A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens.

Saved in:
Bibliographic Details
Title: A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens.
Authors: Kratochvil S; Imperial College London, Medicine, London, UK., McKay PF; Imperial College London, Medicine, London, UK., Kopycinski JT; Nuffield, University of Oxford, Medicine, Oxford, UK., Bishop C; Flow Cytometry Core Facility, Biomedical Research Centre, Guy's Hospital, London, UK., Hayes PJ; Human Immunology Laboratory, IAVI, London, UK., Muir L; Imperial College London, Medicine, London, UK., Pinder CL; Imperial College London, Medicine, London, UK., Cizmeci D; Imperial College London, Medicine, London, UK., King D; Human Immunology Laboratory, IAVI, London, UK., Aldon Y; Imperial College London, Medicine, London, UK., Wines BD; Burnet Institute, Melbourne, VIC, Australia., Hogarth PM; Burnet Institute, Melbourne, VIC, Australia., Chung AW; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Kent SJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia.; Melbourne Sexual Health Centre, Department of Infectious Diseases, Alfred Health, Central Clinical School, Monash University, Melbourne, VIC, Australia., Held K; Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany., Geldmacher C; Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany., Dally L; Emmes Corporation, Rockville, MD, USA., Santos NS; NIHR/Wellcome Trust Imperial Clinical Research Facility Hammersmith Hospital, Imperial College London, London, UK., Cole T; NIHR/Wellcome Trust Imperial Clinical Research Facility Hammersmith Hospital, Imperial College London, London, UK., Gilmour J; Human Immunology Laboratory, IAVI, London, UK., Fidler S; Imperial College London, Medicine, London, UK., Shattock RJ; Imperial College London, Medicine, London, UK.
Source: Frontiers in immunology [Front Immunol] 2017 May 24; Vol. 8, pp. 595. Date of Electronic Publication: 2017 May 24 (Print Publication: 2017).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2017.00595